Course summary

About this course Utilising the world leading expertise of University of Liverpool academics in the field, the MSc Precision Medicine programme aims to give students a broad understanding of concepts and research around how modern medicine and drug development is utilising a more personalised approach to improve the effectiveness and safety of medicines. Introduction The programme’s mission is centred around improving patient treatment through the optimisation, of current treatments, understanding variability in patient responses from both an efficacy and safety perspective, and formulation of advanced personalised therapeutics, such as gene and cellular therapies. The programme is led by internationally recognised clinical and non-clinical experts in the field of pharmacology, toxicology, and precision medicine based in the world-renowned Wolfson centre for Personalised Medicine at the University of Liverpool. In addition, teaching will be delivered by experts in the field from the biotechnology and pharma industry. At the heart of the programme are modules centred around key topics in the field of pharmacology and personalised medicine. Advances in Personalised Healthcare will provide students with learning opportunities in understanding the principle of pharmacogenomics as well as other examples of personalised or stratified healthcare in both clinical and drug development settings. Linked to this is the Experimental Medicine and Clinical Pharmacology module, where students will learn how clinical trials are conducted, and how risk assessment needs to be managed in early phase trials, particularly for these new therapeutic modalities. Who is this course for? This programme is suitable for biomedical, biological and clinical sciences graduates but also those in industry or healthcare professions What you'll learn Students on this programme will learn:

• How precision medicine principles are applied to modern healthcare.

• How advance bio-analysis methodologies can used and applied in a personalised medicine setting.

• How large clinical datasets can be analysed and used to advance our understanding of an individual’s response to treatment.

• How personalised drug treatments are revolutionising the way we treat range of conditions.